We are studying a new CAR T cell treatment for patients with relapsed or refractory Multiple Myeloma. The trial aims to evaluate its safety and effectiveness in improving patient outcomes.
We are exploring different therapies for children and adolescents with acute myeloid leukemia to see if they improve survival and treatment outcomes. This includes testing new drugs alongside standard chemotherapy.
We are investigating how well dupilumab works for adults and adolescents with eosinophilic gastritis, with or without eosinophilic duodenitis. The study will also look at the safety and side effects of this treatment.
We are investigating the safety and effectiveness of linvoseltamab in patients with newly diagnosed multiple myeloma who have not yet received treatment. This study will help us understand how well this new therapy works for different patient groups.
We are testing different amounts of KTX-1001 to see if it is safe and tolerable for people with relapsed or treatment-resistant multiple myeloma.
We are studying a new treatment combination for patients with advanced non-small cell lung cancer who have not had prior therapy. The goal is to see if this combination works better than standard treatments in improving survival and reducing disease progression.
We are studying whether adding flecainide to metoprolol can better reduce irregular heartbeats in patients with arrhythmic mitral valve prolapse. This trial aims to assess the safety and effectiveness of this combination treatment.
We are studying a new method of delivering a targeted treatment for men with high-risk prostate cancer before surgery. The goal is to evaluate its safety and how well it works compared to standard approaches.
We are testing a new treatment for people with advanced solid tumors to see how safe it is and how well it works. This study will help us learn more about its effects in humans.
We are investigating whether colchicine can help prevent the return of atrial fibrillation in patients scheduled for heart rhythm treatment. We will also look at its effects on heart health and quality of life.
We are exploring a new approach for individuals with chronic obstructive pulmonary disease (COPD). The goal is to see if this treatment can improve breathing and overall health.
We are investigating the safety and effects of NGI226 microparticles for patients with Achilles tendinopathy. This study aims to see if it helps restore tendon strength compared to a placebo.
We are studying a new therapy called reconsolidation therapy for people with severe PTSD. This trial compares it to standard treatment and looks at whether adding propranolol can improve outcomes.
We are exploring how to personalize acyclovir dosages for individuals with obesity. This study aims to improve treatment effectiveness and safety for this patient group.
We are studying whether influenza vaccination can help protect insulin-producing cells in individuals with early type 1 diabetes. This research aims to find new ways to support diabetes management.
We are studying whether daily aspirin can help prevent preeclampsia and improve pregnancy outcomes in women who are pregnant for the first time after assisted reproductive technology. This trial compares aspirin to a placebo to see which is more effective.
We are comparing two treatment methods for operable esophageal squamous cell carcinoma to see which may help patients survive longer. The study also examines quality of life and other health impacts during and after treatment.
We are comparing a new way to give a combination treatment for advanced melanoma to see if it works as well as the traditional method. This study is for people who have not yet been treated for their melanoma.
We are studying whether full-dose anticoagulant therapy alone is safer and more effective than combining it with antiplatelet therapy for patients with acute VTE. This research aims to improve treatment options for those already taking antiplatelets.
We are studying a new treatment combining pembrolizumab with chemotherapy for patients with advanced Merkel cell carcinoma. The goal is to see if this combination is effective and safe for those who haven't been treated before.